Skip to content

Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia

Effect of Vitamin D and Statins on Plasma Lipid Profiles in Chinese Patients With Hypercholesterolemia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02009787
Enrollment
56
Registered
2013-12-12
Start date
2013-12-31
Completion date
2015-01-31
Last updated
2013-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Hypercholesterolemia

Keywords

hypercholesterolemia; vitamin D; adjuvant therapy

Brief summary

The investigators planned to research the effect of vitamin D supplementation as an adjuvant therapy for patients with hypercholesterolemia.

Detailed description

Vitamin D is primarily generated in the skin, in response to direct absorption of ultraviolet B radiation. Vitamin D can also be obtained through fortified foods and oral supplements. Lipid abnormalities are common in the general population, and are regarded as a modifiable risk factor for cardiovascular disease. Recently low vitamin D status has been shown to be associated with increased risk of developing hyperlipidemia. Statins are normally the first-line therapy for hypercholesterolemia. It is also reported that vitamin D can improve serum lipid levels. However, its effects on hypercholesterolemia patients remain unclear. The investigators planned to determine the efficacy of combination therapy with statins and vitamin D in a cohort of hypercholesterolemia patients. This study may shed light as to whether oral vitamin D supplementation can be an adjunct therapy in hypercholesterolemia patients.

Interventions

2000 IU vitamin D3 tablets were taken daily for 6 months

DRUGplacebo tablets

2000 IU placebo tablets were taken daily for 6 months

Sponsors

Shi Yang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

The main inclusion criteria were for hypercholesterolemia patients with the treatment of statins.

Exclusion criteria

The

Design outcomes

Primary

MeasureTime frameDescription
a change in serum total cholesterol levelafter 6 months of vitamin D supplementationThe primary end point was a change in serum total cholesterol level after 6 months of vitamin D supplementation.

Secondary

MeasureTime frameDescription
a change in serum triglycerides levelafter 6 months of vitamin D supplementationThe change in serum triglycerides level was measured after 6 months of vitamin D supplementation.
differences in the incidences of treatment-emergent adverse eventsafter 6 months of vitamin D supplementationTreatment-emergent adverse events (TEAEs): hypercalcemia, renal insufficiency, constipation

Countries

China

Contacts

Primary ContactYang Shi, M.D.
ggyyong@sina.com+8610-66876231

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026